TOPIC TAGS for this article:
Pharma + Biotech, Litigation
Click on a topic to display all headlines on that subject
SSJR Wins Summary Judgment in Contract Case
12 May 2015
SSJR successfully defended and had dismissed various breach of contracted related claims filed against its client ChemWerth, Inc. by medical device company Bryan Corporation in Bryan Corp. v. ChemWerth.
A Massachusetts Federal Court recently granted SSJR’s Motion for Summary Judgment of No Contract and SSJR’s Motion for Summary Judgment Dismissing or Limiting Damages on Bryan Corp.’s Promissory Estoppel Claim. The Court ruled that no enforceable contract was entered by ChemWerth and Bryan Corp. and that there was insufficient grounds for Bryan Corp.’s promissory estoppel claim against ChemWerth. In the same Court Order, the District Court also denied Bryan Corp.’s Motion for Partial Summary Judgment on these and other claims; and denied in part Third Party Defendant Waldman’s Motion for Summary Judgment seeking to dismiss ChemWerth’s claims holding Waldman, Bryan Corp.’s consultant, responsible for Bryan Corp.’s damages.
Having eliminated majority of the claims brought by Bryan Corp., ChemWerth is ready to pursue its counterclaims and affirmative claims at a September 2015 trial. Bryan Corp. is represented by Dan Johnson from Covington & Burling LLP and Waldman is represented by Scott Fink from Pasquarello Fink LLC.
Established in 1982 by Peter J. Werth, Jr., ChemWerth is a full service generic drug development and supply company providing high quality Active Pharmaceutical Ingredients to regulated markets worldwide.